CEO Diederik van der Reijt discusses Celljevity's vision for revolutionizing healthcare through cellular therapy and the company's ambitious growth plans.
Celljevity's innovative approach to making advanced cellular therapies accessible to broader populations through strategic partnerships and global expansion.
Revolutionary cellular reprogramming technology shows promising results in reversing biological aging markers and restoring cellular function.
Former trader turned biotech entrepreneur Diederik van der Reijt leads breakthrough developments in cellular rejuvenation technology at Celljevity.
Medical Disclaimer: Celljevity's Prometheus technology is investigational and not FDA-approved. Research protocol options vary by jurisdiction. Individual results may vary. Not evaluated by the FDA. Not intended to diagnose, treat, cure, or prevent disease. Consult your healthcare provider.